Cargando…

Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA

BACKGROUND: The pathogenesis of malaria is primarily associated with blood-stage infection and there is strong evidence that antibodies specific for parasite blood-stage antigens can control parasitaemia. This provides a strong rationale for incorporation of asexual blood-stage antigen components in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Favuzza, Paola, Blaser, Simon, Dreyer, Anita M., Riccio, Guy, Tamborrini, Marco, Thoma, Ralf, Matile, Hugues, Pluschke, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791974/ https://www.ncbi.nlm.nih.gov/pubmed/26979066 http://dx.doi.org/10.1186/s12936-016-1213-x

Ejemplares similares

Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody
por: Favuzza, Paola, et al.
Publicado: (2017)

Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models
por: Tamborrini, Marco, et al.
Publicado: (2020)

Cysteine-Rich Protective Antigen (CyRPA) as promising blood-stage candidate protein for inclusion in a malaria subunit vaccine
por: Favuzza, Paola, et al.
Publicado: (2012)

Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA
por: Chen, Lin, et al.
Publicado: (2017)

Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against Plasmodium falciparum CyRPA
por: Knudsen, Anne S., et al.
Publicado: (2021)

Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
por: Healer, Julie, et al.
Publicado: (2019)

Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites
por: Knuepfer, Ellen, et al.
Publicado: (2019)

The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
por: Ragotte, Robert J., et al.
Publicado: (2020)

Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
por: Nacer, Adéla, et al.
Publicado: (2022)

Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA)
por: Somanathan, Anjali, et al.
Publicado: (2022)

The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals
por: Tamborrini, Marco, et al.
Publicado: (2023)

Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
por: Azasi, Yvonne, et al.
Publicado: (2020)

RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
por: Healer, Julie, et al.
Publicado: (2022)

Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate
por: Fernandes, Bárbara, et al.
Publicado: (2022)

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
por: Weiss, Greta E., et al.
Publicado: (2023)

Generation of monoclonal antibodies against native viral proteins using antigen-expressing mammalian cells for mouse immunization
por: Rose, Natalie, et al.
Publicado: (2016)

An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
por: Dreyer, Anita M, et al.
Publicado: (2010)

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
por: Tamborrini, Marco, et al.
Publicado: (2011)

Genetic Diversity of Plasmodium vivax Cysteine-Rich Protective Antigen (PvCyRPA) in Field Isolates from Five Different Areas of the Brazilian Amazon
por: Bitencourt Chaves, Lana, et al.
Publicado: (2021)

Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine
por: Tamborrini, Marco, et al.
Publicado: (2009)

A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity
por: Tritten, Lucienne, et al.
Publicado: (2009)

Using Cy5-dUTP labelling of RPA-amplicons with downstream microarray analysis for the detection of antibiotic resistance genes
por: Warmt, Christian, et al.
Publicado: (2021)

Standardizing estimates of the Plasmodium falciparum parasite rate
por: Smith, David L, et al.
Publicado: (2007)

Transcriptional variation in the malaria parasite Plasmodium falciparum
por: Rovira-Graells, Núria, et al.
Publicado: (2012)

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax
Publicado: (1982)

Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
por: de Jong, Roos M., et al.
Publicado: (2019)

Inhibitory Potential of Prodomain of Plasmodium falciparum Protease Serine Repeat Antigen 5 for Asexual Blood Stages of Parasite
por: Alam, Asrar, et al.
Publicado: (2012)

Inhibitory Compounds Targeting Plasmodium falciparum Gyrase B
por: Pakosz, Zuzanna, et al.
Publicado: (2021)

The protein-phosphatome of the human malaria parasite Plasmodium falciparum
por: Wilkes, Jonathan M, et al.
Publicado: (2008)

Chloroquine-Resistant Haplotype Plasmodium falciparum Parasites, Haiti
por: Londono, Berlin L., et al.
Publicado: (2009)

Origin of the human malaria parasite Plasmodium falciparum in gorillas
por: Liu, Weimin, et al.
Publicado: (2010)

Alternative Protein Secretion in the Malaria Parasite Plasmodium falciparum
por: Thavayogarajah, Thuvaraka, et al.
Publicado: (2015)

Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites
por: Belachew, Esmael Besufikad
Publicado: (2018)

Immune Responses to the Sexual Stages of Plasmodium falciparum Parasites
por: Kengne-Ouafo, Jonas A., et al.
Publicado: (2019)

Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species
por: Silbereisen, Angelika, et al.
Publicado: (2015)

Inhibitory effects of erythrocyte membrane proteins on the in vitro invasion of the human malarial parasite (Plasmodium falciparum) into its host cell
Publicado: (1981)

A Distinct Peripheral Blood Monocyte Phenotype Is Associated with Parasite Inhibitory Activity in Acute Uncomplicated Plasmodium falciparum Malaria
por: Chimma, Pattamawan, et al.
Publicado: (2009)

Polyamine uptake in the malaria parasite, Plasmodium falciparum, is dependent on the parasite's membrane potential
por: Niemand, J, et al.
Publicado: (2010)

Polyamine uptake in the malaria parasite, Plasmodium falciparum, is dependent on the parasite's membrane potential
por: Niemand, J, et al.
Publicado: (2010)

Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors
por: Saito, Fumiji, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hj7vpfor0mp7ncabmqfm8lmn8k